Literature DB >> 18370523

Use of transdermal fentanyl in cancer patients with intestinal problems: four case studies.

P Naughton1, P Horan.   

Abstract

Entities:  

Year:  1998        PMID： 18370523     DOI： 10.2165/00044011-199816010-00012

Source DB:  PubMed          Journal:  Clin Drug Investig        ISSN： 1173-2563            Impact factor:   2.859


× No keyword cloud information.
  4 in total

1.  Comparison of the analgesic and intestinal effects of fentanyl and morphine in rats.

Authors:  A A Megens; K Artois; J Vermeire; T Meert; F H Awouters
Journal:  J Pain Symptom Manage       Date:  1998-04       Impact factor: 3.612

2.  Transdermal fentanyl versus sustained-release oral morphine in cancer pain: preference, efficacy, and quality of life. The TTS-Fentanyl Comparative Trial Group.

Authors:  S Ahmedzai; D Brooks
Journal:  J Pain Symptom Manage       Date:  1997-05       Impact factor: 3.612

3.  Direct conversion from oral morphine to transdermal fentanyl: a multicenter study in patients with cancer pain.

Authors:  Barbara Donner; Michael Zenz; Michael Tryba; Michael Strumpf
Journal:  Pain       Date:  1996-03       Impact factor: 6.961

4.  Transdermal fentanyl and initial dose-finding with patient-controlled analgesia in cancer pain. A pilot study with 20 terminally ill cancer patients.

Authors:  Detlev F J Zech; Stefan U A Grond; John Lynch; Hans G Dauer; Bernd Stollenwerk; Klaus A Lehmann
Journal:  Pain       Date:  1992-09       Impact factor: 6.961
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.